October 2008 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” 5-alpha reductase inhibitors do not increase hip fracture risk.
April 2008 in “Sexologies” Knowing about potential side effects can make them more likely to happen.
March 2008 in “European Urology Supplements” Finasteride and dutasteride can affect sexual function in BPH patients.
St John’s Wort can change how finasteride works in the body.
January 2008 in “Lishizhen Medicine and Materia Medica Research” The root extract of Untica mairei Levl may help treat benign prostatic hyperplasia.
January 2008 in “Journal of Beijing Normal University” Terazosin hydrochloride helps with BPH and blood pressure, but not more than the control.
June 2007 in “Nature Clinical Practice Urology” Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.
PLX, a tomato extract mix, may help treat prostate issues like BPH.
February 2007 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.
January 2007 in “Annals of The Royal College of Surgeons of England” Removing a hormone-producing adrenal tumor can stop hair loss in women with high testosterone levels.
Long-term finasteride use may affect sperm structure and chromosomes.
October 2006 in “Urology” Finasteride may help treat BPH by affecting certain biological markers.
October 2006 in “Urology” The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.
October 2006 in “Urology” Combination therapy with Finasteride is more effective than alpha-blocker alone for BPH symptoms in small prostate volume.
October 2006 in “Urology” The document aimed to understand how certain treatments affect blood vessel growth in rat prostates.
April 2006 in “The Journal of Urology” Genetic variations may affect how well finasteride works for BPH patients.
January 2006 in “Zhongguo yaofang” Qianliekang and liuweidihuangwan are cheaper for BPH treatment than finasteride and tamsulosin.
January 2006 in “OpenMETU (Middle East Technical University)” The same drug is priced differently based on its use.
December 2005 in “Current Prostate Reports” In 2005, men used finasteride mainly to treat an enlarged prostate.
January 2005 in “Urologia Journal” 5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.
January 2005 in “Psychoneuroendocrinology” Finasteride may affect brain chemistry and behavior, offering potential for treating certain mental health conditions.
Evidence-based urology improved treatment and quality of life for conditions like BPH by shifting from surgery to effective medications like finasteride and dutasteride.
January 2005 in “Journal of Clinical Urology” Taking finasteride for at least 3 months before TURP reduces blood loss.
January 2005 in “国外医药:植物药分册” African plum is linked to treating BPH and has economic benefits.
December 2004 in “SUNScholar (Stellenbosch University)” Certain genetic markers can indicate a person's risk of developing prostate cancer.
September 2004 in “Urology” Finasteride may reduce prostate cancer risk.
August 2004 in “Medisch-Farmaceutische Mededelingen” Long-term use of finasteride may cause breast cancer in men.
April 2004 in “Journal watch” Finasteride effectively reduces the need for surgery and urinary issues in men with BPH over the long term.
April 2004 in “Medisch-Farmaceutische Mededelingen” Finasteride may help reduce prostate cancer risk.
January 2004 in “Anticancer Research” Long-term antiandrogen use may increase aggressive prostate cancer risk.